Villavarayan Chris
Villavarayan Chris's purchase track record
Villavarayan Chris has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/4/2023 | AXTA | $1.00M | +1.9% | +12.7% | +10.7% |
| 3/13/2023 | AXTA | $1.01M | +9.9% | -7.4% | +16.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Franklin Electric (FELE) Cited As Undervalued On Cash Flow. Recent analysis suggests Franklin Electric shares may be trading below their intrinsic value, with one view highlighting a potential 21% discount based on cash flow metrics. Another perspective points to improving profit margins as a key driver for the stock's current valuation. These reports provide context for the company's financial health, noting that the stock currently trades near the lower end of its 52-week range.
Transaction History
| AXTA | ▲ Buy | Option Exercise | 26,246 | — | 3/4/2026 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 12,053 | $378K | 3/4/2026 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 23,265 | $737K | 3/3/2026 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 96,354 | — | 3/3/2026 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 44,246 | $1.4M | 3/3/2026 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 50,663 | — | 3/3/2026 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 11,609 | $388K | 2/28/2026 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 24,631 | — | 2/28/2026 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 11,311 | $378K | 2/28/2026 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 25,280 | — | 2/28/2026 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 25,280 | — | 2/28/2025 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 11,562 | $419K | 2/28/2025 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 24,631 | — | 2/28/2025 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 11,314 | $410K | 2/28/2025 | View on chart |
| FELE | ▲ Buy | Grant | 2,415 | $0 | 5/2/2024 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 25,279 | — | 2/28/2024 | View on chart |
| AXTA | ▼ Sell | Tax Withholding | 10,711 | $348K | 2/28/2024 | View on chart |
| AXTA | ▲ Buy | Open Market | 33,710 | $1.0M | 8/4/2023 | View on chart |
| FELE | ▲ Buy | Option Exercise | 1,246 | $119K | 5/6/2023 | View on chart |
| FELE | ▼ Sell | Other | 1 | $83 | 5/6/2023 | View on chart |
| AXTA | ▲ Buy | Open Market | 34,440 | $1.0M | 3/13/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
UBS Cuts Axalta Price Target to $36, Maintains Neutral Rating
UBS lowered its price target for Axalta to $36 while keeping a neutral stance. The company also announced the date for its third-quarter 2026 earnings call. These updates provide new context as Axalta trades near its 52-week low, with the stock currently sitting above a key support level.
UBS Cuts Axalta Price Target to $36, Maintains Neutral Rating. UBS lowered its price target for Axalta to $36 while keeping a neutral stance. The company also announced the date for its third-quarter 2026 earnings call. These updates provide new context as Axalta trades near its 52-week low, with the stock currently sitting above a key support level.